Q: Would WELL be ok for a RESP or is the risk too high? Have 14 years before the grandchild turn 18. Currently only have VGRO and looking at adding some other names.
Q: Correction to my previous question
Hi,
How is the balance sheet and cashflow of CLIQ. Does it have some growth potential or is it considered as an income stock.
Thank you
Q: Is SYZ a potential take over candidate? I’m thinking about adding to a half position. Any particular reason why it trades at a p/e multiple (q1 annualized) that is significantly lower then the other software companies in Canada. Any reason you think one of those consolidators hasn’t looked at it (constellation, open text, enghouse etc)? Thanks
Q: Peter and His Wonder Team
What do you think about there restructuring plans while under bankruptcy protection? Do they have a chance of surviving. Will the stock remain a penny stock or might it have a little bounce here based on "a wing and a pray"?
Is zero inevitable or am I being too pessimistic?
Thanks for your opinion!
Q: Hi there, in the context of unintended consequences I find that Roots shareholders may benefit in the near to mid term. Closing stores(unfortunately appears to help their business model profitability) and having their new D.C. (e-commerce channel)become more reliable and more efficient is beneficial. Strong brand and quality product all looking good. Is their balance sheet and liquidity strong enough to come out the other end of the Covid crisis? Thx Chris
Q: Last question for today.
Is this a company with good growth potential and financially sound. Are there other companies that are competing directly against them or they have a niche approach?
Q: hi
Could I have your opinion on their latest results and buy, sell or hold rating? What do you think of their pipeline of future products and research?
thanks
François
What is your valued opinion of Kneat these days?
The last question on Nov 2019 indicated the sales valuation at 12x was concerning. Has that number come down enough for you to be more favourable as a spec buy.
They recently had another good quarter (Q1) with good % increases (albeit likely from a small base). They seem to be signing a number of contract wins last few quarters and I like that it is a SaaS based revenue model company.
Who might their other competitors be in this field? And any idea what their market penetration might be, for the competitors or for Kneat?
It would be for a spec buy and to initiate a 1/3 position.
Q: I have been holding QST for a while and am down 67%. Would you keep holding or consider a switch into XBC? Do you have any other suggestions for replacing QST?